Correction to Lancet Neurol 2022; 21: 355–68 (The Lancet Neurology (2022) 21(4) (355–368), (S1474442221003768), (10.1016/S1474-4422(21)00376-8))

摘要

? 2022 Elsevier LtdGutierrez J, Turan TN, Hoh BL, Chimowitz MI. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 2022; published online Feb 7. https://doi.org/10.1016/S1474-4422(21)00376-8—In this Review, the first sentence of the fourth paragraph in Conclusions and future directions should read “The results from the CASSISS study119 and the RICA trial will provide more insight into the role of endovascular treatment and ischaemic conditioning, respectively, in the management of ICAS.” This correction has been made to the online version as of Feb 16, 2022, and will be made to the printed version.